(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally...
Stats | |
---|---|
本日の出来高 | 25 879.00 |
平均出来高 | 19 952.00 |
時価総額 | 695.20M |
EPS | $0 ( 2024-02-26 ) |
次の収益日 | ( $0 ) 2024-05-06 |
Last Dividend | $2.20 ( 2023-11-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 35.78 |
ATR14 | $3.46 (0.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-08 | Ferguson Cindy | Sell | 163 | restricted stock units |
2024-03-08 | Ferguson Cindy | Buy | 163 | common stock |
2024-03-08 | Ferguson Cindy | Sell | 45 | common stock |
2024-01-02 | Stupp John P Jr | Buy | 10 | stock units |
2024-01-02 | Ferguson Cindy | Buy | 14 | restricted stock units |
INSIDER POWER |
---|
-4.44 |
Last 93 transactions |
Buy: 23 820 | Sell: 40 633 |
Atrion Corp 相関
10 最も負の相関 | |
---|---|
FRHC | -0.869 |
MTRY | -0.861 |
KSICU | -0.859 |
AVDL | -0.859 |
MORF | -0.859 |
COKE | -0.859 |
DKNG | -0.854 |
OTTR | -0.844 |
NBSTU | -0.842 |
PTOC | -0.839 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Atrion Corp 財務諸表
Annual | 2023 |
収益: | $169.33M |
総利益: | $62.39M (36.84 %) |
EPS: | $11.02 |
FY | 2023 |
収益: | $169.33M |
総利益: | $62.39M (36.84 %) |
EPS: | $11.02 |
FY | 2022 |
収益: | $183.51M |
総利益: | $75.90M (41.36 %) |
EPS: | $19.59 |
FY | 2021 |
収益: | $165.01M |
総利益: | $69.37M (42.04 %) |
EPS: | $18.00 |
Financial Reports:
No articles found.
Atrion Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.20 (N/A) |
$2.20 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.183 | 1990-02-12 |
Last Dividend | $2.20 | 2023-11-30 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 117 | -- |
Total Paid Out | $94.61 | -- |
Avg. Dividend % Per Year | 0.85% | -- |
Score | 4.71 | -- |
Div. Sustainability Score | 9.69 | |
Div.Growth Potential Score | 2.80 | |
Div. Directional Score | 6.24 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0.732 | 9.87% |
1991 | $0.732 | 7.71% |
1992 | $0.783 | 7.12% |
1993 | $0.800 | 5.27% |
1994 | $0.800 | 5.78% |
1995 | $0.800 | 7.27% |
1996 | $0.800 | 5.60% |
1997 | $0.600 | 3.87% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0.240 | 1.07% |
2004 | $0.520 | 1.14% |
2005 | $0.620 | 1.33% |
2006 | $0.740 | 1.09% |
2007 | $0.880 | 1.12% |
2008 | $1.080 | 0.87% |
2009 | $1.320 | 1.36% |
2010 | $10.56 | 6.78% |
2011 | $1.820 | 0.97% |
2012 | $12.10 | 5.03% |
2013 | $2.40 | 1.19% |
2014 | $2.78 | 0.96% |
2015 | $3.30 | 0.97% |
2016 | $3.90 | 1.04% |
2017 | $4.50 | 0.90% |
2018 | $5.10 | 0.82% |
2019 | $5.80 | 0.79% |
2020 | $6.60 | 0.89% |
2021 | $7.40 | 1.13% |
2022 | $8.20 | 1.17% |
2023 | $8.70 | 1.53% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.115 | 1.500 | 7.71 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0744 | 1.200 | 7.52 | 9.02 | [0 - 0.3] |
returnOnEquityTTM | 0.0807 | 1.500 | -0.215 | -0.322 | [0.1 - 1] |
payoutRatioTTM | 0.789 | -1.000 | 2.11 | -2.11 | [0 - 1] |
currentRatioTTM | 9.09 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.32 | 0.800 | 1.057 | 0.845 | [0.8 - 2.5] |
cashRatioTTM | 0.282 | 1.500 | 9.54 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.000920 | -1.500 | 9.98 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -9.13 | 1.000 | -4.49 | -4.49 | [3 - 30] |
operatingCashFlowPerShareTTM | 11.37 | 2.00 | 6.21 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -1.314 | 2.00 | -0.657 | -1.314 | [0 - 20] |
debtEquityRatioTTM | 0.000988 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.368 | 1.000 | 7.19 | 7.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.117 | 1.000 | 9.66 | 9.66 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 83.36 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.649 | 0.800 | 9.01 | 7.20 | [0.5 - 2] |
Total Score | 9.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 35.82 | 1.000 | 6.48 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0807 | 2.50 | -0.138 | -0.322 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.314 | 2.00 | -0.438 | -1.314 | [0 - 30] |
dividendYielPercentageTTM | 2.22 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 11.37 | 2.00 | 6.21 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.789 | 1.500 | 2.11 | -2.11 | [0 - 1] |
pegRatioTTM | -10.20 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.118 | 1.000 | 9.55 | 0 | [0.1 - 0.5] |
Total Score | 2.80 |
Atrion Corp
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。